SCHEMBL4159335

SCHEMBL4159335

O=C1C(=O)N(COc2cccnc2)c2ccccc21

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 1/20 0.57
CES1 P23141 6/20 0.50
BCHE P06276 3/20 0.50
TGM2 P21980 1/20 0.50
ALDH1A1 P00352 7/20 0.47
MEN1 O00255 1/20 0.47
KMT2A Q03164 1/20 0.47
NPSR1 Q6W5P4 1/20 0.47
ALDH3A1 P30838 5/20 0.46
ALDH2 P05091 3/20 0.46
CHRM1 P11229 2/20 0.46
MAOA P21397 1/20 0.44
MAOB P27338 1/20 0.44
PARK7 Q99497 1/20 0.43
CASP3 P42574 1/20 0.43
CASP7 P55210 1/20 0.43
ACHE P22303 1/20 0.43
CA1 P00915 1/20 0.43
CA2 P00918 1/20 0.43
CES2 O00748 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8616895 0.84 HTT (0.53) ALDH1A1MEN1KMT2A
SCHEMBL4158450 0.84 CES1 (0.61) CES1BCHETGM2ALDH1A1MEN1
SCHEMBL4625203 0.76 CES1 (0.69) HPGDCES1BCHETGM2ALDH1A1
SCHEMBL7212044 0.72 RAB9A (0.70) HPGDKMT2ANPSR1
SCHEMBL3331215 0.71 CES1 (0.65) CES1BCHETGM2ALDH1A1ALDH3A1
SCHEMBL12930188 0.70 ALDH1A1 (0.71) HPGDCES1BCHETGM2ALDH1A1
SCHEMBL25707219 0.69 CES1 (0.61) CES1BCHETGM2ALDH1A1ALDH3A1
SCHEMBL19924204 0.69 CES1 (1.00) CES1BCHETGM2ALDH1A1ALDH3A1
SCHEMBL26930330 0.69 TGM2 (1.00) CES1BCHETGM2ALDH1A1ALDH3A1
SCHEMBL4624390 0.68 ALDH3A1 (0.76) CES1BCHETGM2ALDH1A1ALDH3A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8329686-B2 Isatin analogues and uses therefor WASHINGTON UNIVERSITY (US) 2012-12-11 US disclosed
US-20090068105-A1 ISATIN ANALOGUES AND USES THEREFOR WASHINGTON UNIVERSITY IN ST. LOUIS 2009-03-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090068105-A1 ISATIN ANALOGUES AND USES THEREFOR CASP7, CASP3, HASPIN HPGD 2314/4885CES1 1158/4885BCHE 745/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.